MedTrace Logo

Mucoid Staphylococcus Aureus in Cystic Fibrosis Airways

NCT04171583 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 628

Last updated 2023-02-02

No results posted yet for this study

Summary

Recently, the investigators described a new mucoid phenotype of Staphylococcus aureus cultured from the airways of cystic fibrosis (CF) patients.In this observational study, the investigators plan to determine the prevalence of mucoid S. aureus in respiratory specimens of CF patients and a possible impact of mucoid S. aureus on lung disease severity.

Conditions

  • Staphylococcus Aureus Pneumonia
  • Lung Diseases
  • Cystic Fibrosis
  • Lung Function Decreased

Sponsors & Collaborators

  • University Hospital Muenster

    lead OTHER

Principal Investigators

  • Barbara C Kahl, MD · University Hospital Muenster

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-01
Primary Completion
2022-07-31
Completion
2022-07-31

Countries

  • Austria
  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04171583 on ClinicalTrials.gov